Skip to main content
SpringerLink
Log in

Anesthesia Practices in Colorectal Cancer Surgery

  • Chapter
  • First Online:
Colon Polyps and Colorectal Cancer

  • 1196 Accesses

Abstract

In patients with colorectal cancer (CRC), factors such as increased age, comorbid disease, adverse physiopathological effects of drugs used in cancer treatment, and organ failures associated with tumor size and metastases, which increase the incidence of comorbidities and cause metabolic changes that alter pharmacokinetic and pharmacodynamic properties of anesthetic agents, make already risky anesthesia practices more challenging. These patients often have high-risk scores in the American Society of Anesthesiologists (ASA) scoring, which is used to assess anesthesia risk in the preoperative period.

According to the current research, decisions made by an anesthetist in colorectal surgery such as any of the general, regional, or neuraxial anesthetic techniques, anesthetic-analgesic agents chosen and perioperative blood transfusion may have positive or negative effects on colorectal cancer recurrence or long-term survival rates.

Inhalation agents of sevoflurane, desflurane, and xenon, intravenous anesthetics of propofol, analgesics of COX inhibitor nonsteroidal anti-inflammatory agents (NSAIDs), anesthetic techniques of epidural block or regional block with general anesthesia, and local anesthetics used in these blocks can be safely used in CRC patients. In addition, these anesthetic agents and techniques have the potential to produce positive effects on CRC prognosis. However, the effects of dexmedetomidine, ketamine, opioids, and β-blockers are controversial. Care should be taken in the selection and dosing of these agents. Blood transfusion and hypothermia are known to have adverse effects in all surgical procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749. https://doi.org/10.1001/jamaoncol.2019.2996.

    Article  PubMed Central  Google Scholar 

  2. Araz C. Anesthesia for cancer patients. JARSS. 2014;22(1):3–12.

    Google Scholar 

  3. Hurwitz EE, Simon M, Vinta SR, et al. Adding examples to the ASA-Physical Status classification improves correct assignments to patients. Anesthesiology. 2017;126:614–22.

    Article  PubMed  Google Scholar 

  4. https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system.

  5. Peng YN, Huang ML, Kao CH. Prevalence of depression and anxiety in colorectal cancer patients: a literature review. Int J Environ Res Public Health. 2019;16(3):411.

    Article  PubMed Central  Google Scholar 

  6. Barrett-Bernstein M, Carli F, Gamsa A, Scheede-Bergdahl C, Minnella E, Ramanakumar AV, Tourian L. Depression and functional status in colorectal cancer patients awaiting surgery: impact of a multimodal prehabilitation program. Health Psychol. 2019;38(10):900–9.

    Article  PubMed  Google Scholar 

  7. Butterworth JF, Mackey DC, Wasnick JD, Morgan GE, Mikhail MS. Cardiovascular monitoring. In: Morgan GE, Mikhail MS, editors. Clinical anesthesiology. 5th ed. New York, NY: McGraw-Hill; 2013. p. 87–122.

    Google Scholar 

  8. Fernandes A, Rodrigues J, Lages P, Lança S, Mendes P, Antunes L, Santos CS, Castro C, Costa RS, Lopes CS, da Costa PM, Santos LL. Root causes and outcomes of postoperative pulmonary complications after abdominal surgery: a retrospective observational cohort study. Patient Saf Surg. 2019;13:40.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J, Sabaté S, Mazo V, Briones Z, Sanchis J, ARISCAT Group. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338–50.

    Article  PubMed  Google Scholar 

  10. Moningi S, Patki A, Padhy N, Ramachandran G. Enhanced recovery after surgery: an anesthesiologist’s perspective. J Anaesthesiol Clin Pharmacol. 2019;35(Suppl 1):S5–S13.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, Rockall TA, Young-Fadok TM, Hill AG, Soop M, de Boer HD, Urman RD, Chang GJ, Fichera A, Kessler H, Grass F, Whang EE, Fawcett WJ, Carli F, Lobo DN, Rollins KE, Balfour A, Baldini G, Riedel B, Ljungqvist O. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS®) society recommendations: 2018. World J Surg. 2019;43(3):659–95.

    Article  CAS  PubMed  Google Scholar 

  12. Dang Y, Shi X, Xu W, Zuo M. The effect of anesthesia on the immune system in colorectal cancer patients. Can J Gastroenterol Hepatol. 2018;2018:7940603.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Paarnio K, Tuomisto A, Väyrynen SA, Väyrynen JP, Klintrup K, Ohtonen P, Mäkinen MJ, Mäkelä J, Karttunen TJ. Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome. APMIS. 2019;127(8):561–9.

    Article  CAS  PubMed  Google Scholar 

  14. Ohashi K, Wang Z, Yang YM, Billet S, Tu W, Pimienta M, Cassel SL, Pandol SJ, Lu SC, Sutterwala FS, Bhowmick N, Seki E. NOD-like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in NAFLD. Hepatology. 2019;70(5):1582–99.

    Article  CAS  PubMed  Google Scholar 

  15. Krijgsman D, de Vries NL, Skovbo A, Andersen MN, Swets M, Bastiaannet E, Vahrmeijer AL, van de Velde CJH, Heemskerk MHM, Hokland M, Kuppen PJK. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer Immunol Immunother. 2019;68(6):1011–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wu Y, Yuan L, Lu Q, Xu H, He X. Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer. Oncol Lett. 2018;15(3):3876–82.

    PubMed  PubMed Central  Google Scholar 

  17. Angka L, Martel AB, Kilgour M, Jeong A, Sadiq M, de Souza CT, Baker L, Kennedy MA, Kekre N, Auer RC. Natural killer cell IFNγ secretion is profoundly suppressed following colorectal cancer surgery. Ann Surg Oncol. 2018;25(12):3747–54.

    Article  PubMed  Google Scholar 

  18. Sun X, Yang C, Li K, Ding S. The impact of anesthetic techniques on survival for patients with colorectal cancer: evidence based on six studies. Hepato-Gastroenterology. 2015;62(138):299–302.

    PubMed  Google Scholar 

  19. Chen WK, Ren L, Wei Y, et al. General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. Int J Color Dis. 2015;30:475–81.

    Article  Google Scholar 

  20. Hou BJ, Du Y, Gu SX, Fan J, Wang R, Deng H, Guo DX, Wang L, Wang YY. General anesthesia combined with epidural anesthesia maintaining appropriate anesthesia depth may protect excessive production of inflammatory cytokines and stress hormones in colon cancer patients during and after surgery. Medicine (Baltimore). 2019;98(30):e16610.

    Article  CAS  Google Scholar 

  21. Xu YJ, Li SY, Cheng Q, Chen WK, Wang SL, Ren Y, Miao CH. Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia. 2016;71(2):147–54.

    Article  CAS  PubMed  Google Scholar 

  22. Apfel CC, Cakmakkaya OS, Kolodzie K, Pace NL. Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database Syst Rev. 2014;(11):CD008877. https://doi.org/10.1002/14651858.CD008877.

  23. Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010;113(1):27–34.

    Article  PubMed  Google Scholar 

  24. Missair A, Cata JP, Votta-Velis G, Johnson M, Borgeat A, Tiouririne M, Gottumukkala V, Buggy D, Vallejo R, Marrero EB, Sessler DO, Huntoon MA, Andres J, Casasola OL. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Reg Anesth Pain Med. 2019;44(1):13–28.

    Article  PubMed  Google Scholar 

  25. Huitink JM, Heimerikxs M, Nieuwland M, Loer SA, Brugman W, Velds A, Sie D, Kerkhoven RM. Volatile anesthetics modulate gene expression in breast and brain tumor cells. Anesth Analg. 2010;111(6):1411–5.

    Article  CAS  PubMed  Google Scholar 

  26. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331–9.

    Article  CAS  PubMed  Google Scholar 

  27. Buschmann D, Brandes F, Lindemann A, Maerte M, Ganschow P, Chouker A, Schelling G, Pfaffl MW, Reithmair M. Propofol and sevoflurane differentially impact MicroRNAs in circulating extracellular vesicles during colorectal cancer resection: a pilot study. Anesthesiology. 2020;132(1):107–20.

    Article  PubMed  Google Scholar 

  28. Sun SQ, Ren LJ, Liu J, Wang P, Shan SM. Sevoflurane inhibits migration and invasion of colorectal cancer cells by regulating microRNA-34a/ADAM10 axis. Neoplasma. 2019;66(6):887–95.

    Article  CAS  PubMed  Google Scholar 

  29. Fan L, Wu Y, Wang J, He J, Han X. Sevoflurane inhibits the migration and invasion of colorectal cancer cells through regulating ERK/MMP-9 pathway by up-regulating miR-203. Eur J Pharmacol. 2019;850:43–52.

    Article  CAS  PubMed  Google Scholar 

  30. Müller-Edenborn B, Roth-Z’graggen B, Bartnicka K, Borgeat A, Hoos A, Borsig L, Beck-Schimmer B. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology. 2012;117(2):293–301.

    Article  CAS  PubMed  Google Scholar 

  31. Margarit SC, Vasian HN, Balla E, Vesa S, Ionescu DC. The influence of total intravenous anaesthesia and isoflurane anaesthesia on plasma interleukin-6 and interleukin-10 concentrations after colorectal surgery for cancer: a randomised controlled trial. Eur J Anaesthesiol. 2014;31(12):678–84.

    Article  CAS  PubMed  Google Scholar 

  32. Fleischmann E, Marschalek C, Schlemitz K, Dalton JE, Gruenberger T, Herbst F, Kurz A, Sessler DI. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol. 2009;9:1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ash SA, Valchev GI, Looney M, Ni Mhathuna A, Crowley PD, Gallagher HC, Buggy DJ. Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: comparison with sevoflurane. Br J Anaesth. 2014;113(Suppl 1):i14–21.

    Article  CAS  PubMed  Google Scholar 

  34. Ren YL, Zhang W. Propofol promotes apoptosis of colorectal cancer cells via alleviating the suppression of lncRNA HOXA11-AS on miRNA let-7i. Biochem Cell Biol. 2020;98:90. https://doi.org/10.1139/bcb-2018-0235.

    Article  CAS  PubMed  Google Scholar 

  35. Liu D, Sun X, Du Y, Kong M. Propofol promotes activity and tumor-killing ability of natural killer cells in peripheral blood of patients with colon cancer. Med Sci Monit. 2018;3(24):6119–28.

    Article  Google Scholar 

  36. Chen X, Wu Q, Sun P, Zhao Y, Zhu M, Miao C. Propofol disrupts aerobic glycolysis in colorectal cancer cells via inactivation of the NMDAR-CAMKII-ERK pathway. Cell Physiol Biochem. 2018;46(2):492–504.

    Article  CAS  PubMed  Google Scholar 

  37. Xu K, Tao W, Su Z. Propofol prevents IL-13-induced epithelial-mesenchymal transition in human colorectal cancer cells. Cell Biol Int. 2018;42(8):985–93.

    Article  CAS  PubMed  Google Scholar 

  38. Deng F, Ouyang M, Wang X, Yao X, Chen Y, Tao T, Sun X, Xu L, Tang J, Zhao L. Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application. Oncotarget. 2016;7(47):77087–95.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Duan W, Hu J, Liu Y. Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor. Exp Mol Pathol. 2019;107:171–8.

    Article  CAS  PubMed  Google Scholar 

  40. Horiguchi Y, Ohta N, Yamamoto S, Koide M, Fujino Y. Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling. Int Immunopharmacol. 2019;66:373–82.

    Article  CAS  PubMed  Google Scholar 

  41. Ku SC, Ho PS, Tseng YT, Yeh TC, Cheng SL, Liang CS. Benzodiazepine-associated carcinogenesis: focus on lorazepam-associated cancer biomarker changes in overweight individuals. Psychiatry Investig. 2018;15(9):900–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ding S, Ma H, Wang G, Yu Z, Li K, Huang A. Effect of remifentanil combined anesthesia on cytokines and oxidative stress in patients undergoing laparoscopic surgery for colon cancer. J Coll Physicians Surg Pak. 2019;29(1):8–11.

    Article  PubMed  Google Scholar 

  43. Diaz-Cambronero O, Mazzinari G, Cata JP. Perioperative opioids and colorectal cancer recurrence: a systematic review of the literature. Pain Manag. 2018;8(5):353–61.

    Article  PubMed  Google Scholar 

  44. Seaton ME, Peters U, Johnson KC, Kooperberg C, Bafford A, Zubair N. Effects of colorectal cancer risk factors on the association between aspirin and colorectal cancer. Anticancer Res. 2019;39(9):4877–84.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Rodríguez-Miguel A, García-Rodríguez LA, Gil M, Barreira-Hernández D, Rodríguez-Martín S, de Abajo FJ. Population-based case-control study: chemoprotection of colorectal cancer with non-aspirin nonsteroidal anti-inflammatory drugs and other drugs for pain control. Aliment Pharmacol Ther. 2019;50(3):295–305.

    Article  CAS  PubMed  Google Scholar 

  46. Mormile R. NSAID use and colorectal cancer-letter. Cancer Epidemiol Biomark Prev. 2018;27(12):1536.

    Article  Google Scholar 

  47. Li T, Chen L, Zhao H, Wu L, Masters J, Han C, Hirota K, Ma D. Both bupivacaine and levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro. J Anesth. 2019;33(1):17–25.

    Article  PubMed  Google Scholar 

  48. Qu X, Yang L, Shi Q, Wang X, Wang D, Wu G. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR. Pathol Res Pract. 2018;214(12):1974–9.

    Article  CAS  PubMed  Google Scholar 

  49. Bundscherer A, Malsy M, Gebhardt K, Metterlein T, Plank C, Wiese CH, Gruber M, Graf BM. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res. 2015;95–96:126–31.

    Article  CAS  PubMed  Google Scholar 

  50. Jansen L, Weberpals J, Kuiper JG, Vissers PAJ, Wolkewitz M, Hoffmeister M, Brenner H. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: results from a population-based study. Int J Cancer. 2017;141(1):62–71.

    Article  CAS  PubMed  Google Scholar 

  51. Kwon HY, Kim BR, Kim YW. Association of preoperative anemia and perioperative allogenic red blood cell transfusion with oncologic outcomes in patients with nonmetastatic colorectal cancer. Curr Oncol. 2019;26(3):e357–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. McSorley ST, Tham A, Dolan RD, Steele CW, Ramsingh J, Roxburgh C, Horgan PG, McMillan DC. Perioperative blood transfusion is associated with postoperative systemic inflammatory response and poorer outcomes following surgery for colorectal cancer. Ann Surg Oncol. 2020;27:833. https://doi.org/10.1245/s10434-019-07984-7.

    Article  PubMed  Google Scholar 

  53. Yücel Y, Barlan M, Lenhardt R, Kurz A, Sessler DI. Perioperative hypothermia does not enhance the risk of cancer dissemination. Am J Surg. 2005;189(6):651–5.

    Article  PubMed  Google Scholar 

  54. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010;110(6):1636–43.

    Article  PubMed  Google Scholar 

  55. Chang WK, Tai YH, Lin SP, Wu HL, Tsou MY, Chang KY. An investigation of the relationships between postoperative pain trajectories and outcomes after surgery for colorectal cancer. J Chin Med Assoc. 2019;82(11):865–71.

    Article  PubMed  Google Scholar 

  56. Radovanović D, Radovanović Z, Škorić-Jokić S, Tatić M, Mandić A, Ivković-Kapicl T. Thoracic epidural versus intravenous patient-controlled analgesia after open colorectal cancer surgery. Acta Clin Croat. 2017;56(2):244–54.

    Article  PubMed  Google Scholar 

  57. Tai YH, Chang WK, Wu HL, Chan MY, Chen HH, Chang KY. The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: a retrospective cohort study. PLoS One. 2018;13(7):e0200893.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anesthesiology and Reanimation Department, Tepecik Training and Research Hospital, Health Sciences University, Izmir, Turkey

    Yucel Karaman

Authors
  1. Yucel Karaman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, Izmir Tepecik Training and Research Hospital, Konak, Izmir, Turkey

    Omer Engin

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Karaman, Y. (2021). Anesthesia Practices in Colorectal Cancer Surgery. In: Engin, O. (eds) Colon Polyps and Colorectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-57273-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-57273-0_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-57272-3

  • Online ISBN: 978-3-030-57273-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation